H M Cheng - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

H M Cheng

Showing results (191-200 of 194) with videos related to

Pageof 20

Sort By:

You have reached the last page of results.This site can display upto 194 results.

Proceedings of the National Academy of Sciences of the United States of America|March 13, 2023

Unexpected catalytic activity of nanorippled grapheneP Z Sun, W Q Xiong, A Bera, et al.

Nature Medicine|October 3, 2022

Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trialJeremy Pettus, Schafer C Boeder, Mark P Christiansen, et al.

Nature Medicine|March 18, 2023

Publisher Correction: Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trialJeremy Pettus, Schafer C Boeder, Mark P Christiansen, et al.

Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|August 5, 2024

The Hong Kong Renal Registry: a recent updateJ Y H Chan, Y L Cheng, S K Yuen, et al.

Pageof 20

Search research articles

Showing results (191-200 of 194) with videos related to

Sort By:

Pageof 20

You have reached the last page of results.This site can display upto 194 results.

Proceedings of the National Academy of Sciences of the United States of America|March 13, 2023

Unexpected catalytic activity of nanorippled grapheneP Z Sun, W Q Xiong, A Bera, et al.

Nature Medicine|October 3, 2022

Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trialJeremy Pettus, Schafer C Boeder, Mark P Christiansen, et al.

Nature Medicine|March 18, 2023

Publisher Correction: Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trialJeremy Pettus, Schafer C Boeder, Mark P Christiansen, et al.

Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|August 5, 2024

The Hong Kong Renal Registry: a recent updateJ Y H Chan, Y L Cheng, S K Yuen, et al.

Pageof 20